Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.
Bengala C, Bettelli S, Bertolini F, Salvi S, Chiara S, Sonaglio C, Losi L, Bigiani N, Sartori G, Dealis C, Malavasi N, D'Amico R, Luppi G, Gatteschi B, Maiorana A, Conte PF. Bengala C, et al. Among authors: malavasi n. Ann Oncol. 2009 Mar;20(3):469-74. doi: 10.1093/annonc/mdn647. Epub 2008 Dec 18. Ann Oncol. 2009. PMID: 19095777 Free article.
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, Malavasi N, Scolaro T, Depenni R, Jovic G, Sonaglio C, Rossi A, Luppi G, Conte PF. Bertolini F, et al. Among authors: malavasi n. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):466-72. doi: 10.1016/j.ijrobp.2008.04.065. Epub 2008 Nov 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19004567 Clinical Trial.
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.
Bengala C, Bertolini F, Malavasi N, Boni C, Aitini E, Dealis C, Zironi S, Depenni R, Fontana A, Del Giovane C, Luppi G, Conte P. Bengala C, et al. Among authors: malavasi n. Br J Cancer. 2010 Jan 5;102(1):68-72. doi: 10.1038/sj.bjc.6605458. Epub 2009 Nov 24. Br J Cancer. 2010. PMID: 19935794 Free PMC article. Clinical Trial.
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, Depenni R, Zironi S, Del Giovane C, Luppi G, Conte PF. Bengala C, et al. Among authors: malavasi n. Br J Cancer. 2010 Sep 28;103(7):1019-24. doi: 10.1038/sj.bjc.6605853. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842128 Free PMC article.
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer.
Bertolini F, Malavasi N, Scarabelli L, Fiocchi F, Bagni B, Del Giovane C, Colucci G, Gerunda GE, Depenni R, Zironi S, Fontana A, Pettorelli E, Luppi G, Conte PF. Bertolini F, et al. Among authors: malavasi n. Br J Cancer. 2011 Mar 29;104(7):1079-84. doi: 10.1038/bjc.2011.43. Epub 2011 Mar 8. Br J Cancer. 2011. PMID: 21386839 Free PMC article. Clinical Trial.
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, Depenni R, Zironi S, Del Giovane C, Luppi G, Conte PF. Bengala C, et al. Among authors: malavasi n. Br J Cancer. 2024 Sep;131(5):954. doi: 10.1038/s41416-024-02790-9. Br J Cancer. 2024. PMID: 39117801 Free article. No abstract available.
17 results